Aggressive breast cancer linked to African ancestry

Weill Cornell Medicine investigators have identified definitive biological links between African ancestry and disease processes that affect an aggressive cancer type called triple-negative breast cancer.

Alzheimer’s disease causes major metabolic changes in the brain

New findings could lead to the development of treatments aimed at ameliorating the metabolic effects of the disease.

Protecting privacy – and safety – in encrypted messaging

Cornell Tech researchers have developed a mechanism for preserving anonymity in encrypted messaging – which conceals message content but might not cloak the sender’s identity – while simultaneously blocking unwanted or abusive messages.

$61M grant funds translational science at Weill Cornell Medicine

This is the largest federal grant ever awarded to Weill Cornell Medicine and the fourth consecutive time this initiative has been funded by the NIH, representing 20 years of continuous funding.

Cells help immune system tolerate friendly gut bacteria

Immune cells called group 3 innate lymphoid cells play an essential role in establishing tolerance to symbiotic microbes that dwell in the human gastrointestinal tract, according to a study led by researchers at Weill Cornell Medicine.

Researchers identify the target of immune attacks on liver cells

A new study from Weill Cornell Medicine researchers helps to explain the dynamics underlying liver damage that can accompany type 2 diabetes and obesity. 

Vaccination exposes latent HIV in lab studies

Vaccination with a SARS-CoV-2 mRNA vaccine revealed HIV hiding in immune cells in blood from people with HIV, according to lab research led by Weill Cornell Medicine investigators.

Six assistant professors win NSF early-career awards

Researchers studying carbon removal and storage methods and novel additive manufacturing techniques are among the six Cornell faculty members who recently received National Science Foundation Faculty Early Career Development Awards.

Staff News

Two-medication strategy offers benefits and risks after bypass surgery

A new analysis shows that a combination of two anti-platelets drugs can benefit patients after the most common type of cardiac surgery – while also increasing the risk of potentially dangerous bleeding.